PARP1 and neoplasm: As HIPK2 is a tumor suppressor and mediator of DNA damage-induced apoptosis, our results propose a new measure to improve the efficiency of genotoxic cancer therapies possibly by interfering with the PARP1 WGR-HIPK2 interaction.